NFKB1 and breast carcinoma: Moreover, in breast cancer cell lines, NOSC showed a dose-dependent cytotoxic effect, presumably by the nuclear factor kappa-light-chain-enhancer of an activated B-cell (NF-kβ) pathway inhibition [36].